Sale!

Plasmodium Species RNA Detection Qualitative Test

Original price was: $140.Current price is: $120.

-14%

The Plasmodium Species RNA Detection Qualitative Test is a cutting-edge molecular diagnostic tool that identifies malaria parasites through RNA detection. Using Real-Time RT-PCR technology, this test provides highly sensitive and specific detection of all Plasmodium species causing malaria. It’s particularly valuable for early diagnosis, monitoring treatment response, and detecting low-level infections that might be missed by conventional methods. The test requires whole blood or dried blood spot samples and delivers results within 36-48 hours. Priced at $120 USD, this advanced molecular test offers superior accuracy for malaria diagnosis and management, helping healthcare providers make informed treatment decisions and prevent disease complications.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Plasmodium Species RNA Detection Qualitative Test

Comprehensive Malaria Diagnosis Through Advanced Molecular Testing

The Plasmodium Species RNA Detection Qualitative Test represents a significant advancement in malaria diagnostics, utilizing cutting-edge Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) technology to detect malaria parasites with exceptional accuracy. This molecular test specifically targets Plasmodium RNA, providing superior sensitivity compared to traditional microscopy and rapid diagnostic tests, particularly in cases of low parasitemia or mixed infections.

What Does This Test Detect?

This sophisticated diagnostic test identifies the presence of Plasmodium species RNA in blood samples, enabling detection of:

  • Plasmodium falciparum (the most dangerous malaria species)
  • Plasmodium vivax
  • Plasmodium malariae
  • Plasmodium ovale
  • Plasmodium knowlesi
  • Mixed Plasmodium infections

By targeting RNA rather than DNA or antigens, this test provides active infection detection and can identify parasites even during the early stages of infection when parasite levels are minimal.

Who Should Consider This Test?

Symptoms and Risk Factors

This test is recommended for individuals experiencing symptoms suggestive of malaria or those with specific risk factors:

  • Fever and Chills: Recurrent or cyclical fever patterns characteristic of malaria
  • Travel History: Recent travel to malaria-endemic regions
  • Flu-like Symptoms: Headache, muscle aches, fatigue, and nausea
  • Post-Travel Monitoring: Individuals returning from high-risk areas
  • Treatment Monitoring: Patients undergoing malaria treatment to assess response
  • Diagnostic Challenges: Cases where conventional tests are negative but clinical suspicion remains high
  • Immunocompromised Patients: Those with weakened immune systems at higher risk

Key Benefits of RNA Detection Testing

Superior Diagnostic Accuracy

The Plasmodium Species RNA Detection Test offers multiple advantages over traditional diagnostic methods:

  • Early Detection: Identifies infections before symptoms become severe
  • High Sensitivity: Detects as few as 1-5 parasites per microliter of blood
  • Species Identification: Differentiates between malaria species for targeted treatment
  • Treatment Monitoring: Tracks parasite clearance during therapy
  • No Cross-Reactivity: Eliminates false positives from other infections
  • Quantitative Potential: Can provide semi-quantitative data on parasite load

Understanding Your Test Results

Interpretation Guidelines

Your test results will be clearly presented and interpreted by our expert team:

  • Positive Result: Indicates active Plasmodium infection requiring immediate medical attention and appropriate antimalarial treatment
  • Negative Result: Suggests no detectable Plasmodium RNA in the sample, though clinical correlation is essential
  • Species Identification: Specific Plasmodium species detected will be reported to guide targeted therapy
  • Clinical Correlation: Results should always be interpreted in context with symptoms, travel history, and other clinical findings

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $120
Regular Price $140

Test Details

  • Test Name: Plasmodium Species RNA Detection Qualitative Test
  • Sample Type: Whole blood or dried blood spot
  • Turnaround Time: 36 hours by phone, 48 hours by email
  • Methodology: Real-Time RT-PCR
  • Specialty: Infectious Diseases / Genetics

Pre-Test Instructions

To ensure accurate results, please follow these preparation guidelines:

  • Sign the required consent document before testing
  • >Bring any available clinical history related to malaria symptoms or travel

  • No fasting required for this test
  • Inform your healthcare provider about any current medications
  • Provide complete travel history and symptom timeline

Nationwide Testing Availability

GGC DNA provides comprehensive Plasmodium Species RNA Detection testing across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.

Take Action Against Malaria Today

Early and accurate diagnosis is crucial for effective malaria treatment and prevention of complications. Don’t wait for symptoms to worsen – schedule your Plasmodium Species RNA Detection Test now and get the definitive answers you need for proper medical management.

Ready to schedule your test? Call our dedicated healthcare team at +1(267) 388-9828 or book your appointment online today. Our expert staff is available to answer your questions and guide you through the testing process.

With rapid turnaround times, competitive pricing at only $120 USD, and nationwide accessibility, GGC DNA makes advanced malaria diagnostics accessible to everyone across the United States. Trust the leaders in molecular diagnostics for your malaria testing needs.